ZEB1 and colorectal carcinoma: They demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in CRC cells and suggested that modulation of miR-200c with inhibitors or mimics could serve as a therapeutic tool for inhibiting metastasis in CRC.